5-BenzyloxyindoleCAS# 1215-59-4 |
Quality Control & MSDS
Number of papers citing our products
Chemical structure
3D structure
Cas No. | 1215-59-4 | SDF | Download SDF |
PubChem ID | 14624 | Appearance | Powder |
Formula | C15H13NO | M.Wt | 223.3 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Solubility | Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc. | ||
Chemical Name | 5-phenylmethoxy-1H-indole | ||
SMILES | C1=CC=C(C=C1)COC2=CC3=C(C=C2)NC=C3 | ||
Standard InChIKey | JCQLPDZCNSVBMS-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C15H13NO/c1-2-4-12(5-3-1)11-17-14-6-7-15-13(10-14)8-9-16-15/h1-10,16H,11H2 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
5-Benzyloxyindole Dilution Calculator
5-Benzyloxyindole Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 4.4783 mL | 22.3914 mL | 44.7828 mL | 89.5656 mL | 111.957 mL |
5 mM | 0.8957 mL | 4.4783 mL | 8.9566 mL | 17.9131 mL | 22.3914 mL |
10 mM | 0.4478 mL | 2.2391 mL | 4.4783 mL | 8.9566 mL | 11.1957 mL |
50 mM | 0.0896 mL | 0.4478 mL | 0.8957 mL | 1.7913 mL | 2.2391 mL |
100 mM | 0.0448 mL | 0.2239 mL | 0.4478 mL | 0.8957 mL | 1.1196 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
- Daclatasvir (BMS-790052)
Catalog No.:BCC2533
CAS No.:1214735-16-6
- Ajugapantin A
Catalog No.:BCN3663
CAS No.:121449-67-0
- WZ4003
Catalog No.:BCC4363
CAS No.:1214265-58-3
- WZ8040
Catalog No.:BCC1075
CAS No.:1214265-57-2
- WZ3146
Catalog No.:BCC4004
CAS No.:1214265-56-1
- POM 1
Catalog No.:BCC7454
CAS No.:12141-67-2
- N6-Benzyladenine
Catalog No.:BCC9076
CAS No.:1214-39-7
- Bernardioside A
Catalog No.:BCN7862
CAS No.:121368-52-3
- SR 33805 oxalate
Catalog No.:BCC7181
CAS No.:121346-33-6
- Fmoc-Glu-OH
Catalog No.:BCC3489
CAS No.:121343-82-6
- WZ4002
Catalog No.:BCC1074
CAS No.:1213269-23-8
- 1-Hydroxybisabola-2,10-dien-4-one
Catalog No.:BCN7297
CAS No.:1213251-45-6
- PF-04991532
Catalog No.:BCC8094
CAS No.:1215197-37-7
- Salvianolic acid B; Lithospermic acid B; Danfensuan B
Catalog No.:BCC8249
CAS No.:121521-90-2
- SR 58611A hydrochloride
Catalog No.:BCC7833
CAS No.:121524-09-2
- GR 144053 trihydrochloride
Catalog No.:BCC6998
CAS No.:1215333-48-4
- RG2833
Catalog No.:BCC1893
CAS No.:1215493-56-3
- CFM 1571 hydrochloride
Catalog No.:BCC5924
CAS No.:1215548-30-3
- SB 242084
Catalog No.:BCC5949
CAS No.:1215566-78-1
- RS 100329 hydrochloride
Catalog No.:BCC5741
CAS No.:1215654-26-4
- CP-809101 hydrochloride
Catalog No.:BCC1499
CAS No.:1215721-40-6
- NBI 27914 hydrochloride
Catalog No.:BCC7124
CAS No.:1215766-76-9
- Gatifloxacin hydrochloride
Catalog No.:BCC4224
CAS No.:121577-32-0
- DMCM hydrochloride
Catalog No.:BCC7560
CAS No.:1215833-62-7
Synthesis and biological evaluation of novel oxophenylarcyriaflavins as potential anticancer agents.[Pubmed:18528573]
Org Biomol Chem. 2008 Jun 21;6(12):2108-17.
We report the synthesis and biological evaluation of new oxophenylarcyriaflavins designed as potential anticancer agents. An efficient synthesis involving palladium-catalyzed Suzuki and Stille reactions is presented, without any indolic protective group. The central ring closure of the scaffold was performed through an electrophilic reaction on the position C-2 of the indole ring. The use of indole and 5-Benzyloxyindole, along with substituted phenyl rings, generated three different scaffolds, which were successively exploited to modulate the structure. The cytotoxicity of the newly designed compounds on four cancer cell lines and activities against three kinases (CDK1, CDK5 and GSK3) were evaluated. Several compounds showed a marked cytotoxicity with IC(50) values in the sub-micromolar range, and induced important cell cycle perturbations, with a G2/M arrest. Some compounds revealed DNA binding properties and were found to inhibit topoisomerase-mediated DNA relaxation of supercoiled DNA, but these properties are not mandatory for a cytotoxic action. A novel lead compound () has been identified and warrants further investigations.
Lasting chemiluminescence of 3-indoleglyoxylyl chloride and its enhancement.[Pubmed:12558035]
Anal Sci. 2003 Jan;19(1):123-7.
The chemiluminescence (CL) intensities of various indole derivatives substituted with a glyoxylyl group at the 3-position and a hydroxyl group at the 5-position of the indole ring were compared upon the addition of H2O2 in alkaline media. The CL intensities of 3-indoleglyoxylyl chloride, 3-indoleglyoxylic acid, 5-hydroxyindole and 5-Benzyloxyindole in CH3CN were 5.9-, 48-, 5.9- and 3.3-fold stronger than that of 3-methylindole. A lasting CL of 3-indoleglyoxylyl chloride was found. Under appropriate conditions, the CL emission reached a maximum within 10 min after the addition of H2O2 in the presence of NaOH, and the intensity was retained for 25 min. One of the final products via the CL reaction of 3-indoleglyoxylyl chloride was indole-3-carboxylic acid. 3-Indoleglyoxylyl chloride emitted light by decompositions via both dioxetane and dioxetanedione. An enhancement effect of beta-cyclodextrin and bovine serum albumin on the CL of 3-indoleglyoxylyl chloride was also found.
Actions of some analogues of 5-hydroxytryptamine on the isolated rat uterus and the rat fundus strip preparations.[Pubmed:13662587]
Br J Pharmacol Chemother. 1959 Jun;14(2):265-72.
The search for substances which antagonize 5-hydroxytryptamine, and for those which act like it, has been extended to cover 5-substituted indoles which are analogues of 5-hydroxytryptamine, rather than analogues of tryptamine like the compounds previously studied by us. The isolated rat uterus and rat fundus strip preparations have been used to determine activity. The relationships between structure and activity of the compounds studied were not the same on the two preparations nor were they the same from one homologous series to another. These differences may be partly explained by the presence of amine oxidase in the rat fundus, as Vane (1959) has suggested, and by supposing that it is absent from the rat uterus. None of the compounds had marked antagonist activity. The most active antagonist on the rat uterus was 3-(2-aminopropyl)-5-Benzyloxyindole, but this was less potent than 5-benzyloxygramine. On the rat fundus strip, however, the only antagonist, 5-benzyloxy-3-(2-dimethylaminoethyl)indole, was more active than 5-benzyloxygramine. On both preparations the most active stimulant was 3-(2-aminopropyl)-5-Benzyloxyindole, which was about half as potent as 5-hydroxytryptamine. The next most active were 3-(2-aminopropyl)-5-methoxyindole and bufotenine.